Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance

UBC Medical Indonesia Tbk.Trade
Saraswanti Indoland Development Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp91 (market cap 500.81B, 1.26M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 1.26M). Which is the better fit depends on your goals.

LABSSWID
Market Cap
576.7B500.81B
Volume
3.48M1.26M
Lot
34.82K12.61K
Turnover
522.79M113.99M
Average Price
150.1390.38
Value
522.79M113.99M
Indicative Equilibrium Price
14891
Indicative Equilibrium Volume
350643

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SWID
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Saraswanti Indoland Development Tbk.

PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.

Read more on SWID